Stocklytics Platform
Asset logo for symbol PRTA
Prothena Corp PLC
PRTA63
$20.78arrow_drop_up1.81%$0.37
Asset logo for symbol PRTA
PRTA63

$20.78

arrow_drop_up1.81%
Key Stats
Open$20.45
Prev. Close$20.33
EPS-0.94
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range20.23
20.95
52 Week Range18.69
56.04
Ratios
EPS-0.94
Fundamentals
Payout Ratio-
Industry average yield2.95%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

PRTA-
US Healthcare Sector-
US Market-
check_circle

PRTA / Market

PRTA exceeded the US Market which returned 0.19% over the last twenty four hours.
warning

PRTA / Healthcare Sector

PRTA lose to the US Healthcare sector which returned 0.52% over the last twenty four hours.

Prothena Corp PLC (PRTA) Statistics

Prothena Corp PLC (PRTA) is a biotechnology company that focuses on the discovery, development, and commercialization of therapies for the treatment of neurodegenerative diseases. The company's primary focus is on developing antibody-based therapies that target misfolded proteins implicated in diseases such as Alzheimer's and Parkinson's. Prothena Corp PLC has a market capitalization of $X and is headquartered in Dublin, Ireland.
When it comes to the valuation metrics, Prothena Corp PLC has a Price/Sales ratio of X. This indicates that the market values each dollar of the company's revenue at X times its sales. Additionally, the company has a Price/Book ratio of X, suggesting that the market values each dollar of the company's net assets at X times its book value. These valuation metrics highlight the market's perception of Prothena Corp PLC's financial performance and potential for future growth.
add Prothena Corp PLC to watchlist

Keep an eye on Prothena Corp PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How much debt does Prothena Corp PLC (PRTA) have?

Prothena Corp PLC (PRTA) has a total debt of $12.12M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$552.01M.
help

How has Prothena Corp PLC (PRTA) stock's performance compared to its sector and the market over the past year?

Over the past year, Prothena Corp PLC (PRTA) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.03%, Prothena Corp PLC has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 60.21%, it has fallen short of the market average. This comparison highlights Prothena Corp PLC's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Prothena Corp PLC (PRTA) stock?

The PE ratio for Prothena Corp PLC (PRTA) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Prothena Corp PLC (PRTA) stock?

The Earnings Per Share (EPS) for Prothena Corp PLC (PRTA), calculated on a diluted basis, is -$0.94. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Prothena Corp PLC (PRTA) stock?

The operating margin for Prothena Corp PLC (PRTA) is 44.22%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Prothena Corp PLC (PRTA) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Prothena Corp PLC (PRTA) is -$90.41M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media